These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1715634)

  • 21. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.
    von Wussow P; Jakschies D; Hochkeppel H; Horisberger M; Hartung K; Deicher H
    Arthritis Rheum; 1989 Jul; 32(7):914-8. PubMed ID: 2751723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of serum interferon with some clinical and humoral signs of systemic lupus erythematosus.
    Matei I; Ghyka G; Savi I; Tudor A
    Med Interne; 1990; 28(4):289-94. PubMed ID: 1713346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
    J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis.
    Hooks JJ; Jordan GW; Cupps T; Moutsopoulos HM; Fauci AS; Notkins AL
    Arthritis Rheum; 1982 Apr; 25(4):396-400. PubMed ID: 6176247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medullasin enhances human natural killer cell activity by a mechanism other than the induction of interferons or interleukin-2.
    Aoki Y; Fukuchi K
    Jpn J Cancer Res; 1987 Jan; 78(1):68-73. PubMed ID: 2434455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An interferon inhibitor in regulating the activity of human natural killer cells].
    Cheknev SB; Narovlianskiĭ ; Amchenkova AM; Ershov FI
    Biull Eksp Biol Med; 1991 Oct; 112(10):395-7. PubMed ID: 1725132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the assay procedures for immune interferon and its determination on lymphocytes from patients with systemic lupus erythematosus (SLE) (author's transl)].
    Suzuki H
    Ryumachi; 1978 Sep; 18(5):308-16. PubMed ID: 725697
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of lupus inclusions by sera from patients with systemic lupus erythematosus.
    Rich SA; Owens TR; Anzola MC; Bartholomew LE
    Arthritis Rheum; 1986 Apr; 29(4):501-7. PubMed ID: 3486663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of interferon system among chronic alcoholics.
    Chadha KC; Whitney RB; Cummings MK; Norman M; Windle M; Stadler I
    Prog Clin Biol Res; 1990; 325():123-33. PubMed ID: 1689066
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum levels of interferons in patients with systemic lupus erythematosus.
    Kim T; Kanayama Y; Negoro N; Okamura M; Takeda T; Inoue T
    Clin Exp Immunol; 1987 Dec; 70(3):562-9. PubMed ID: 2449306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.
    Preble OT; Black RJ; Friedman RM; Klippel JH; Vilcek J
    Science; 1982 Apr; 216(4544):429-31. PubMed ID: 6176024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications.
    Lebon P; Lenoir GR; Fischer A; Lagrue A
    Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1165-7. PubMed ID: 6414612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basis for and perspectives of using interferon in the treatment of systemic lupus erythematosus].
    Siniachenko OV
    Ter Arkh; 1975; 47(11):134-8. PubMed ID: 1224298
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunoregulatory disturbances in human and murine systemic lupus erythematosus.
    Santoro TJ
    Clin Exp Rheumatol; 1986; 4(2):169-74. PubMed ID: 2426025
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus.
    Klippel JH; Carette S; Preble OT; Friedman RM; Grimley PM
    Ann Rheum Dis; 1985 Feb; 44(2):104-8. PubMed ID: 2983625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.